Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

Background: In radiation treatment of locally advanced non-small cell lung cancer (LA-NSCLC), ‘margins’ from internal target volumes to planning target volumes in the range of 12 to 23 mm are reported, and avoiding exposure of the contralateral lung is common practice. We investigated prospectively...

Full description

Bibliographic Details
Main Authors: Cerkl, P. (Author), Clemens, P. (Author), De Vries, A. (Author), De Vries, C. (Author), Hernler, T. (Author), Hitzl, W. (Author), Kazil, M. (Author), Kreuter, C. (Author), Künzler, T. (Author), Meinschad, M. (Author), Pinter, R. (Author), Wurstbauer, K. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
DART-bid
Locally advanced NSCLC
Lung cancer
Margins
Planning
QUANTEC
Radiation dose intensification
VMAT
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items